Hitting Multiple Cellular Targets in Triple-Negative Breast Cancer Using Dual-Action Cisplatin(IV) Prodrugs for Safer Synergistic Chemotherapy-Reference-Cited by-同舟云学术

Hitting Multiple Cellular Targets in Triple-Negative Breast Cancer Using Dual-Action Cisplatin(IV) Prodrugs for Safer Synergistic Chemotherapy

Published:2022-05-06 Issue:6 Volume:8 Page:2349-2362
ISSN:2373-9878
Container-title:ACS Biomaterials Science & Engineering
language:en
Short-container-title:ACS Biomater. Sci. Eng.

Author:

Date Tushar¹,Kuche Kaushik¹,Chaudhari Dasharath¹,Ghadi Rohan¹,Sahel Deepak Kumar²,Chitkara Deepak²^ORCID,Jain Sanyog¹^ORCID

Affiliation:

1. Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Sector 67, Mohali 160062, Punjab, India

2. Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Vidya Vihar, Pilani 333031, Rajasthan, India

Publisher

American Chemical Society (ACS)

Subject

Biomedical Engineering,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.1c01582

Reference48 articles.

1. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

2. Triple-negative breast cancer: therapeutic options

3. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

4. Platinum-based chemotherapy in triple-negative breast cancer

5. Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological studies of nitric oxide-donating piperlongumine derivatives triggered by lysyl oxidase as anti-triple negative breast cancer agents;Fitoterapia;2024-09

2. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer;Carbohydrate Polymers;2024-08

3. Biotin-stapled mixed micelles of lapatinib: Unleashing apoptosis power in triple-negative breast cancer;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-07

4. Nanodrugs based on co-delivery strategies to combat cisplatin resistance;Journal of Controlled Release;2024-06

5. Advancing apoptosis induction in triple negative breast cancer: Empowering treatment with tyrosine-stapled mixed micelles of lapatinib;Journal of Molecular Liquids;2024-05